文献速递心境障碍

双相障碍的神经滋养因子、细胞因子与氧化应激介质及心境状态:系统综述与荟萃分析

Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses.
PubMed 文献 · Br J Psychiatry · 2018-01-01

该系统综述与荟萃分析纳入53项研究(2467例双相障碍患者与2360名健康对照),评估外周血炎症标志物、神经滋养因子和氧化应激标志物在双相障碍不同心境相中的差异。结果显示无单一标志物能区分心境相,但高敏C反应蛋白/白介素-6、脑源性神经营养因子/肿瘤坏死因子-α及可溶性肿瘤坏死因子-α受体1的组合可能区分特定心境相。

要点

  • 无单一外周血标志物能独立区分双相障碍的心境相。
  • 高敏C反应蛋白/白介素-6等标志物组合可能提示特定心境相。
  • 标志物组合有助于区分双相障碍患者与健康对照。

核心结论

  • 联合多种生物标志物可区分双相障碍患者与健康对照,并可能指示特定心境相特征。

研究设计与样本

  • 遵循PRISMA指南的系统综述与荟萃分析,检索Medline、Embase、PsycINFO、SciELO和Web of Science,纳入53项研究,共2467例双相障碍患者和2360名健康对照。

主要发现

  • 高敏C反应蛋白/白介素-6、脑源性神经营养因子/肿瘤坏死因子-α及可溶性肿瘤坏死因子-α受体1的组合可区分特定心境相。

关键数值与推荐

  • 纳入53项研究,含2467例双相障碍患者和2360名健康对照。

临床怎么用

  • 现有证据尚不支持将单一外周血标志物用于双相障碍心境相的临床鉴别。
  • 标志物组合的潜在价值需在纵向研究中进一步验证,暂不宜作为常规临床决策依据。

局限性

  • 未来需在纵向研究中检验这些生物标志物组合的区分效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A reliable biomarker signature for bipolar disorder sensitive to illness phase would be of considerable clinical benefit. Among circulating blood-derived markers there has been a significant amount of research into inflammatory markers, neurotrophins and oxidative stress markers.AimsTo synthesise and interpret existing evidence of inflammatory markers, neurotrophins and oxidative stress markers in bipolar disorder focusing on the mood phase of illness. METHOD: Following PRISMA (Preferred Reporting Items for Systematic reviews and Meta-analyses) guidelines, a systematic review was conducted for studies investigating peripheral biomarkers in bipolar disorder compared with healthy controls. We searched Medline, Embase, PsycINFO, SciELO and Web of Science, and separated studies by bipolar mood phase (mania, depression and euthymia). Extracted data on each biomarker in separate mood phases were synthesised using random-effects model meta-analyses. RESULTS: In total, 53 studies were included, comprising 2467 cases and 2360 controls. Fourteen biomarkers were identified from meta-analyses of three or more studies. No biomarker differentiated mood phase in bipolar disorder individually. Biomarker meta-analyses suggest a combination of high-sensitivity C-reactive protein/interleukin-6, brain derived neurotrophic factor/tumour necrosis factor (TNF)-α and soluble TNF-α receptor 1 can differentiate specific mood phase in bipolar disorder. Several other biomarkers of interest were identified. CONCLUSIONS: Combining biomarker results could differentiate individuals with bipolar disorder from healthy controls and indicate a specific mood-phase signature. Future research should seek to test these combinations of biomarkers in longitudinal studies.Declaration of interestNone.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Rowland T, Perry BI, Upthegrove R, et al. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Br J Psychiatry. 2018. PMID: 30113291. doi:10.1192/bjp.2018.144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。